The distribution of somatostatin binding sites in the brain of gymnotiform fish, Apteronotus leptorhynchus

Hypothalamic- and pituitary-derived growth and reproductive hormones and the control of energy balance in fish

Most endocrine systems in the body are influenced by the hypothalamic-pituitary axis. Within this axis, the hypothalamus delivers precise signals to the pituitary gland, which in turn releases hormones that directly affect target tissues including the liver, thyroid gland, adrenal glands and gonads. This action modulates the release of additional hormones from the sites of action, regulating key physiological processes, including growth, metabolism, stress and reproduction. Pituitary hormones are released by five distinct hormone-producing cell types: somatotropes (which produce growth hormone), thyrotropes (thyrotropin), corticotropes (adrenocorticotropin), lactotropes (prolactin) and gonadotropes (follicle stimulating hormone and luteinizing hormone), each modulated by specific hypothalamic signals. This careful and distinct organization of the hypothalamo-pituitary axis has been classically associated with the existence of many lineal axes (e.g., the hypothalamic-pituitary-gonadal axis) in charge of the control of the different physiological processes. While this traditional concept is valid, it is becoming apparent that hormones produced by the hypothalamo-pituitary axis have diverse effects. For instance, gonadotropin-releasing hormone II has been associated with a suppressive effect on food intake in fish. Likewise, growth hormone has been shown to influence appetite, swimming activity and aggressive behavior in fish. This review will focus on the hypothalamic and pituitary hormones classically involved in regulating growth and reproduction, and will attempt to provide a general overview of the current knowledge on their actions on energy balance and appetite in fish. It will also give a brief perspective of the role of some of these peptides in integrating feeding, metabolism, growth and reproduction.

Somatostatin and somatostatin receptor gene expression in dominant and subordinate males of an African cichlid fish

Somatostatin is a neuropeptide best known for its inhibitory effects on growth hormone secretion and has recently been implicated in the control of social behavior. Several somatostatin receptor subtypes have been identified in vertebrates, but the functional basis for this diversity is still unclear. Here we investigate the expression levels of the somatostatin prepropeptide and two of its receptors, sstR2, and sstR3, in the brains of socially dominant and subordinate Astatotilapia burtoni males using real-time PCR. Dominant males had higher somatostatin prepropeptide and sstR3 expression in hypothalamus compared to subordinate males. Hypothalamic sstR2 expression did not differ. There were no differences in gene expression in the telencephalon. We also observed an interesting difference between dominants and subordinates in the relationship between hypothalamic sstR2 expression and body size. As would be predicted based on the inhibitory effects of somatostatin on somatic growth, sstR2 expression was negatively correlated with body size in dominant males. In contrast sstR2 expression was positively correlated with body size in subordinate males. These results suggest that in A. burtoni social status affects the relationships between somatostatin prepropeptide and receptor gene expression in the hypothalamus and the control of somatic growth.

Neurogenesis and neuronal regeneration in the adult fish brain

Fish are distinctive in their enormous potential to continuously produce new neurons in the adult brain, whereas in mammals adult neurogenesis is restricted to the olfactory bulb and the hippocampus. In fish new neurons are not only generated in structures homologous to those two regions, but also in dozens of other brain areas. In some regions of the fish brain, such as the optic tectum, the new cells remain near the proliferation zones in the course of their further development. In others, as in most subdivisions of the cerebellum, they migrate, often guided by radial glial fibers, to specific target areas. Approximately 50% of the young cells undergo apoptotic cell death, whereas the others survive for the rest of the fish's life. A large number of the surviving cells differentiate into neurons. Two key factors enabling highly efficient brain repair in fish after injuries involve the elimination of damaged cells by apoptosis (instead of necrosis, the dominant type of cell death in mammals) and the replacement of cells lost to injury by newly generated ones. Proteome analysis has suggested well over 100 proteins, including two dozen identified ones, to be involved in the individual steps of this phenomenon of neuronal regeneration.

Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures

1 The fish somatostatin receptor 3 (fsst3) is one of the few somatostatin (SRIF) receptors cloned from a non-mammalian species so far. Here we extended our earlier characterization of this receptor by investigating the guanine nucleotide sensitivity of agonist radioligand binding at the fsst3 receptor recombinantly expressed in CCL39 (Chinese hamster lung fibroblast) cells. Further, we measured somatostatin (SRIF) and cortistatin (CST) analogues stimulated GTPgammaS binding, inhibition of forskolin-stimulated adenylate cyclase (FSAC) and stimulation of phospholipase C (PLC) activities. The present transductional data were then compared with previous radioligand binding and/or second messenger features determined for fsst3 and/or human SRIF receptors (hsst2, hsst3 and hsst5). 2 The GTP analogue guanylylimidodiphosphate (GppNHp) inhibited binding of [125I]CGP 23996 and [125I][Tyr3octreotide by 72 and 83% suggesting preferential labelling of G-protein-coupled fsst3 receptors. By contrast, [125I]LTT-SRIF28 and [125I][Tyr10]CST14 binding was rather GppNHp insensitive (42 and 35% inhibition) suggesting labelling of both coupled and non-coupled receptor states. These results might explain the apparent higher receptor densities determined in saturation experiments with [125I]LTT-SRIF28 and [125I][Tyr10]CST14 (4470 and 4030 fmol mg(-1)) compared with [125I]CGP 23996 and [125I][Tyr3]octreotide (3420 and 1520 fmol mg(-1)). 3 SRIF14 (10 microm)-stimulated specific [35S]GTPgammaS binding by three-fold; SRIF28 and octreotide displayed full agonism, whereas most other ligands displayed 60-80% intrinsic activity compared with SRIF14. SRIF14 and SRIF28 inhibited forskolin-stimulated AC (FSAC) activity by 60%; all tested ligands except BIM 23056 inhibited FSAC with comparable high intrinsic activities. SRIF14 stimulated PLC activity five- to six-fold, as determined by measuring total [3H] IP(x) accumulation; it was rather insensitive to pertussis toxin (PTX, 100 ng ml(-1), 21% inhibition), which suggests the G(q)-family proteins couple to PLC activity. SRIF14, SRIF28 and [Tyr10]CST14 showed full agonism at PLC, whereas all other ligands behaved as partial agonists (20-70% intrinsic activity). BIM 23056, which showed weak partial or no agonism, antagonized SRIF14-induced total [3H]-IP(x) production (pK(B) = 6.83), but failed to block competitively agonist-stimulated [35S]GTPgammaS binding or agonist-induced inhibition of FSAC activity. 4 Comparison of the pharmacological profiles of fsst3 receptors established in GTPgammaS binding, FSAC inhibition and PLC stimulation resulted in low correlations (r = 0.410-0.594). Both rank orders of potency and rank orders of relative efficacy varied in the three second messenger experiments. Significant, although variable correlations were obtained comparing GTPgammaS binding and inhibition of FSAC activity with previously reported affinity profiles of [125I]LTT-SRIF28, [125I][Tyr10]CST14, [125I]CGP 23996, [125I][Tyr3]octreotide (r = 0.75-0.83; 0.68-0.89). By contrast, the PLC stimulation and radioligand-binding profiles did not correlate. 5 Comparison of the functional data (GTPgammaS binding, FSAC inhibition, PLC stimulation) of fsst3 receptors with those of human sst2, sst3, sst5 receptors expressed in CCL39 cells resulted in highest correlation with the hsst5 receptor (r = 0.94, 0.97, 0.49) > hsst2 (0.80, 0.50, n.d.) > hsst3 (0.25, 0.19, 0.17). 6 In summary, fsst3 receptors expressed in CCL39 cells are involved in signalling cascades similar to those reported for mammalian SRIF receptors, suggesting SRIF receptors to be highly conserved in evolution. Binding and functional data showed highest similarity of fsst3 receptors with the human sst5 receptor subtype. Different affinities, receptor densities and GppNHp-sensitivities determined with the four radioligands (agonists) are assumed to results from ligand-specific states of the fsst3-ligand complex. The differences in the rank orders of potency and relative efficacy in the various signalling cascades may be explained by agonist-induced receptor trafficking.

Regulation of somatostatins and their receptors in fish

The multifunctional nature of the somatostatin (SS) family of peptides results from a multifaceted signaling system consisting of many forms of SS peptides that bind to a variety of receptor (SSTR) subtypes. Research in fish has contributed important information about the components, function, evolution, and regulation of this system. Somatostatins or mRNAs encoding SSs have been isolated from over 20 species of fish. Peptides and deduced peptides differ in their amino acid chain length and/or composition, and most species of fish possess more than one form of SS. The structural heterogeneity of SSs results from differential processing of the hormone precursor, preprosomatostatin (PPSS), and from the existence of multiple genes that give rise to multiple PPSSs. The PPSS genes appear to have arisen through a series of gene duplication events over the course of vertebrate evolution. The numerous PPSSs of fish are differentially expressed, both in terms of the distribution among tissues and in terms of the relative abundance within a tissue. Accumulated evidence suggests that nutritional state, season/stage of sexual maturation, and many hormones [insulin (INS), glucagon, growth hormone (GH), insulin-like growth factor-I (IGF-I), and 17beta-estradiol (E2)] regulate the synthesis and release of particular SSs. Fish and mammals possess multiple SSTRs; four different SSTRs have been described in fish and several of these occur as isoforms. SSTRs are also wide spread and are differentially expressed, both in terms of distribution of tissues as well as in terms of relative abundance within tissues. The pattern of distribution of SSTRs may underlie tissue-specific responses of SSs. The synthesis of SSTR mRNA and SS-binding capacity are regulated by nutritional state and numerous hormones (INS, GH, IGF-I, and E2). Accumulated evidence suggests the possibility of both tissue- and subtype-specific mechanisms of regulation. In many instances, there appears to be coordinate regulation of PPSS and of SSTR; such regulation may prove important for many processes, including nutrient homeostasis and growth control.

Somatostatin receptor subtype 1 and subtype 2 mRNA expression is regulated by nutritional state in rainbow trout (Oncorhynchus mykiss)

Somatostatin receptors (sst) mediate the numerous physiological actions (e.g., aspects of growth, development, and metabolism) of the somatostatin family of peptides. In this study, we used rainbow trout (Oncorhynchus mykiss) to establish the pattern of sst subtype 1A, 1B, and 2 mRNA expression in selected tissues (optic tectum of brain, endocrine pancreas, and liver) and to evaluate nutritional regulation of sst expression. Quantitative real-time reverse transcription-PCR, sensitive to less than 100 copies, revealed that sst1s and sst2 was differentially expressed, both in terms of distribution among the tissues of study and in terms of relative abundance within a particular tissue. Under normal physiological (fed) conditions, sst1B levels were two times greater than those of sst1A in all tissues examined and levels of sst2 were 2-5 times greater those of sst1B, except in optic tectum, in which sst1B and sst2 mRNA levels appeared equal. Nutritional state modulated the pattern of sst1 and sst2 mRNAs expression. Fasting for 2 or 6 weeks reduced the expression of sst mRNAs in optic tectum; whereas, fasting increased the expression of sst mRNAs in both pancreas and liver. Re-feeding animals for 2 weeks following a 4-week fast restored mRNA levels to near those in tissues from animals which were fed continuously. These findings indicate that the pattern of sst expression in optic tectum, pancreas, and liver is regulated by nutritional state.

From oscillators to modulators: behavioral and neural control of modulations of the electric organ discharge in the gymnotiform fish, Apteronotus leptorhynchus

The brown ghost (Apteronotus leptorhynchus) is a weakly electric gymnotiform fish that produces wave-like electric organ discharges distinguished by their enormous degree of regularity. Transient modulations of these discharges occur both spontaneously and when stimulating the fish with external electric signals that mimic encounters with a neighboring fish. Two prominent forms of modulations are chirps and gradual frequency rises. Chirps are complex frequency and amplitude modulations lasting between 20 ms and more than 200 ms. Based on their biophysical characteristics, they can be divided into four distinct categories. Gradual frequency rises consist of a rise in discharge frequency, followed by a slow return to baseline frequency. Although the modulatory phase may vary considerably between a few 100 ms and almost 100 s, there is no evidence for the existence of distinct categories of this type of modulation signal. Stimulation of the fish with external electric signals results almost exclusively in the generation of type-2 chirps. This effect is independent of the chirp type generated by the respective individual under non-evoked conditions. By contrast, no proper stimulation condition is known to evoke the other three types of chirps or gradual frequency rises in non-breeding fish. In contrast to the type-2 chirps evoked when subjecting the fish to external electric stimulation, the rate of spontaneously produced chirps is quite low. However, their rate appears to be optimized according to the probability of encountering a conspecific. As a result, the rate of non-evoked chirping is increased during the night when the fish exhibit high locomotor activity and in the time period following external electric stimulation. These, as well as other, observations demonstrate that both the type and rate of modulatory behavior are affected by a variety of behavioral conditions. This diversity at the behavioral level correlates with, and is likely to be causally linked to, the diversity of inputs received by the neurons that control chirps and gradual frequency rises, respectively. These neurons form two distinct sub-nuclei within the central posterior/prepacemaker nucleus in the dorsal thalamus. In vitro tract-tracing experiments have elucidated some of the connections of this complex with other brain regions. Direct input is received from the optic tectum. Indirect input arising from telencephalic and hypothalamic regions, as well as from the preoptic area, is relayed to the central posterior/prepacemaker nucleus via the preglomerular nucleus. Feedback loops may be provided by projections of the central posterior/prepacemaker nucleus to the preglomerular nucleus and the nucleus preopticus periventricularis.

Effects of sex steroid hormones on the expression of somatostatin receptors sst1 and sst5 in goldfish pituitary and forebrain

In the present paper the effects of estradiol and testosterone on the expression of the types 1 and 5 somatostatin receptors (sst1 and sst5) in the goldfish forebrain and pituitary were investigated. Estradiol increased the sst1 expression in both the forebrain and pituitary in a dose- and time-dependent manner. In addition, estradiol also increased the pituitary expression of sst5. On the other hand, testosterone had no effects on the expression of these receptor subtypes. Mature female goldfish were found to have higher sst1 and sst5 expression in the pituitary, as well as a higher expression of sst1 in the forebrain compared to sexually regressed animals. As estradiol treatment increases serum growth hormone levels in goldfish, these data suggest that sst1 and sst5 receptors are likely not directly involved in this aspect of growth hormone release.

Connections between the central posterior/prepacemaker nucleus and hypothalamic areas in the weakly electric fish Apteronotus leptorhynchus: evidence for an indirect, but not a direct, link

The central posterior/prepacemaker nucleus (CP/PPn) of the weakly electric fish Apteronotus leptorhynchus consists of a few thousands of neurons in the dorsal thalamus. Subpopulations of this complex play a crucial role in neural control of transient modulations of the otherwise extremely constant electric organ discharges. Because both the propensity to execute these modulations and the type of modulations produced may vary enormously with the behavioral situation, it has been hypothesized that this behavioral plasticity is, partially, mediated by peptidergic neuromodulators originating from hypothalamic areas. To define the structural basis of this proposed modulatory input, we have in the present study examined the connections between the CP/PPn proper and hypothalamic areas by employing an in vitro tract-tracing technique. Neither anterograde nor retrograde tracing experiments could provide evidence for the existence of a direct link between the CP/PPn proper and hypothalamic areas. However, the results of our investigation suggest an indirect connection between the CP/PPn proper and two hypothalamic regions, the hypothalamus ventralis and the hypothalamus lateralis, with the preglomerular nucleus serving as a relay station.

Somatostatins and their receptors in fish

Somatostatin (SRIF) is a multigene family of peptides. SRIF-14 is conserved with identical primary structure in species across the vertebrates. The presence of multiple SRIF genes has been demonstrated in a number of fish species. Notably, three distinct SRIF genes have been identified in goldfish. One of these genes, which encodes [Pro(2)]SRIF-14, has also been identified in sturgeon and African lungfish, and is closely associated with the amphibian [Pro(2),Met(13)]SRIF-14 gene and mammalian cortistatin gene. The main neuroendocrine role of SRIF-14 peptide that has been determined in fish is the inhibition of pituitary growth hormone secretion. The functions of SRIF-14 variant or larger forms of SRIF peptide and the regulation of SRIF gene expression remain to be explored. Type one and two SRIF receptors have been identified from goldfish and type three SRIF receptor from an electric fish. Fish SRIF receptors display considerable homology to mammalian counterparts in terms of primary structure and negative coupling to adenylate cyclase. The identification of the multiple gene family of SRIF peptides and multiple types of SRIF receptors in fish opens a new avenue for the study of physiological roles of SRIF, and the molecular and cellular mechanisms of SRIF actions in fish.

Arginine Vasotocin Modulates a Sexually Dimorphic Communication Behavior in the Weakly Electric fish APTERONOTUS LEPTORHYNCHUS

South American weakly electric fish produce a variety of electric organ discharge (EOD) amplitude and frequency modulations including chirps or rapid increases in EOD frequency that function as agonistic and courtship and mating displays. In Apteronotus leptorhynchus, chirps are readily evoked by the presence of the EOD of a conspecific or a sinusoidal signal designed to mimic another EOD, and we found that the frequency difference between the discharge of a given animal and that of an EOD mimic is important in determining which of two categories of chirp an animal will produce. Type-I chirps (EOD frequency increases averaging 650Hz and lasting approximately 25ms) are preferentially produced by males in response to EOD mimics with a frequency of 50–200Hz higher or lower than that of their own. The EOD frequency of Apteronotus leptorhynchus is sexually dimorphic: female EODs range from 600 to 800Hz and male EODs range from 800 to 1000Hz. Hence, EOD frequency differences effective in evoking type-I chirps are most likely to occur during male/female interactions. This result supports previous observations that type-I chirps are emitted most often during courtship and mating. Type-II chirps, which consist of shorter-duration frequency increases of approximately 100Hz, occur preferentially in response to EOD mimics that differ from the EOD of the animal by 10–15Hz. Hence these are preferentially evoked when animals of the same sex interact and, as previously suggested, probably represent agonistic displays. Females typically produced only type-II chirps. We also investigated the effects of arginine vasotocin on chirping. This peptide is known to modulate communication and other types of behavior in many species, and we found that arginine vasotocin decreased the production of type-II chirps by males and also increased the production of type-I chirps in a subset of males. The chirping of most females was not significantly affected by arginine vasotocin.

Somatostatin family of peptides and its receptors in fish

Somatostatin (SRIF or SS) is a phylogenetically ancient, multigene family of peptides. SRIF-14 is conserved with identical primary structure in species of all classes of vertebrates. The presence of multiple SRIF genes has been demonstrated in a number of fish species and could extend to tetrapods. Three distinct SRIF genes have been identified in goldfish. One of these genes, which encodes [Pro2]SRIF-14, is also present in sturgeon and African lungfish, and is closely associated with amphibian [Pro2,Met13]SRIF-14 gene and mammalian cortistatin gene. The post-translational processing of SRIF precursors could result in multiple forms of mature SRIF peptides, with differential abundance and tissue- or cell type-specific patterns. The main neuroendocrine role of SRIF-14 peptide that has been determined in fish is the inhibition of pituitary growth hormone secretion. The functions of SRIF-14 variant or larger forms of SRIF peptide and the regulation of SRIF gene expression remain to be explored. Type 1 and type 2 SRIF receptors have been identified from goldfish and a type 3 SRIF receptor has been identified from an electric fish. Fish SRIF receptors display considerable homology with mammalian counterparts in terms of primary structure and negative coupling to adenylate cyclase. Although additional types of receptors remain to be determined, identification of the multiple gene family of SRIF peptides and multiple types of SRIF receptors opens a new avenue for the study of physiological roles of SRIF, and the molecular and cellular mechanisms of SRIF action in fish.Key words: somatostatin, somatostatin receptor, growth hormone, fish.

Molecular cloning and expression of a type-two somatostatin receptor in goldfish brain and pituitary

Somatostatin (SRIF or SS) exerts diverse inhibitory actions through binding to specific receptors. In this study, a SRIF receptor cDNA was cloned and sequenced from goldfish brain using PCR and cDNA library screening. The cDNA encodes a 380-amino acid goldfish type-two SRIF receptor (designated as sst(2)), with seven putative transmembrane domains (TMD) and YANSCANP motif in the seventh TMD, a signature sequence for the mammalian SRIF receptor (sst) family. In addition, the amino acid sequence of the receptor has 61-62% homology to mammalian sst(2), 41-47% homology to other mammalian sst subtypes and 41-43% homology to recently identified fish sst(1) and sst(3) receptors. Both SRIF-14 and [Pro(2)]SRIF-14, two of the native goldfish SRIF forms, but not a putative goldfish SRIF-28, significantly inhibited forskolin-stimulated adenosine 3':5'-cyclic monophosphate (cAMP) release in COS-7 cells transiently expressing goldfish sst(2), suggesting functional coupling of the receptor to adenylate cyclase. None of the three peptides affected inositol phosphate production in the same receptor expression system. Northern blot showed that mRNA for the sst(2) receptor is widely distributed in goldfish brain, and highly expressed in the pituitary. The decrease in pituitary sst(2) mRNA levels following estradiol implantation suggests the presence of a negative feedback mechanism on sst(2) gene expression.

Molecular cloning and pharmacological characterization of a somatostatin receptor subtype in the gymnotiform fish Apteronotus albifrons

The actions of the various forms of somatostatin (SRIF), including those of the tetradecapeptide SRIF(14), are mediated by specific receptors. In mammals, five subtypes of SRIF receptors, termed sst(1-5), have been cloned. Using a combination of reverse transcriptase-polymerase chain reaction and genomic library screening in the gymnotiform fish Apteronotus albifrons, a gene encoding the first-known nonmammalian SRIF receptor has been isolated. The deduced amino acid sequence displays 59% identity with the human sst(3) receptor protein; hence, the gene is termed "Apteronotus sst(3)." The predicted protein consists of 494 amino acid residues exhibiting a putative seven-transmembrane domain topology typical of G protein-coupled receptors. A signal corresponding to the Apteronotus sst(3) receptor was detected in brain after amplification of poly(A)(+)-RNA by reverse transcriptase-polymerase chain reaction, but not by Northern blot analysis or in situ hybridization, suggesting a low level of expression. Membranes prepared from CCL39 cells stably expressing the Apteronotus sst(3) receptor gene bound [(125)I][Leu(8),d-Trp(22), (125) I-Tyr(25)]SRIF(28) with high affinity and in a saturable manner (B(max) = 4470 fmol/mg protein; pK(D) = 10.5). SRIF(14) and various synthetic SRIF receptor agonists produced a dose-dependent inhibition of radioligand binding, with the following rank order of potency: SRIF(14) approximately SRIF(28) > BIM 23052 > octreotide > BIM 23056. Under low stringency conditions, an Apteronotus sst(3) probe hybridized to multiple DNA fragments in HindIII or EcoRI digests of A. albifrons DNA, indicating that the Apteronotus sst(3) receptor is a member of a larger family of Apteronotus SRIF receptors.

Up-regulation of somatostatin after lesions in the cerebellum of the teleost fish Apteronotus leptorhynchus

Following application of mechanical lesions to the corpus cerebelli, a cerebellar subdivision, in adult individuals of the teleost fish Apteronotus leptorhynchus, the pattern of expression of the neuropeptide somatostatin was examined by employing immunohistochemical techniques. In the intact corpus cerebelli, only a very few cells displayed somatostatin-like immunoreactivity. This number dramatically increased in the area of the lesion within the granule cell layer 1 day following the injury and peaked after 2 days, when the normalized total number of somatostatin-positive cells was approximately 50 times higher than the mean number of labeled cells found after 3, 6, and 12 h of survival. Between 5 and 10 days of post-lesioning survival time, this number abruptly declined and returned to background levels at 17 and 25 days. Confocal microscopy revealed three cell types, presumably corresponding to granule cell neurons, astrocytes and microglia, which all displayed a similar temporal pattern of somatostatin expression. It is hypothesized that somatostatin is involved in regulation of the genesis and/or development of new neurons which are produced in response to injuries and which replace damaged cells at the site of the lesion.

Distribution of protein kinase C in the brain of Apteronotus leptorhynchus as revealed by phorbol ester binding

An antibody to the mammalian protein kinase C alpha (PKCalpha) subunit and brain dissection was used for immunoblot analysis of this protein in various brain regions of Apteronotus leptorhynchus. Western blots revealed that the antibody labeled a band of the expected molecular mass (approximately 80 kDa) for this enzyme in mammalian cortex and electric fish brain, suggesting that this protein is also found in gymnotiform brain. The 80-kDa band was enriched in fish forebrain and cerebellum compared with hypothalamus and brainstem areas. [3H]Phorbol 12,13-dibutyrate ([3H]PDBu) binding was used as a marker for the distribution of protein kinase C (PKC). [3H]PDBu binding was nearly completely displaced by excess cold PDBu; specific [3H]PDBu binding sites were heterogenously distributed with high densities in some gray matter regions and negligible densities in fiber tracts. A very high density of [3H]PDBu binding sites were found in the dorsal forebrain with far lower densities in most ventral forebrain nuclei. Low binding densities were observed in preoptic and hypothalamic areas with the exception of the nucleus diffusus and nucleus tuberis anterior. The thalamus and midbrain also had only low levels of binding. The cerebellar molecular layer had dense binding, in contrast to the granule cell layer where binding was negligible. In the electrosensory lateral line lobe (ELL), there was moderate binding in the dorsal molecular layer, which contains cerebellar parallel fibers; the other layers of the ELL had far lower binding densities.

Neurogenesis, cell death and regeneration in the adult gymnotiform brain

Gymnotiform fish, like all teleosts examined thus far, are distinguished by their enormous potential for the production of new neurons in the adult brain. In Apteronotus leptorhynchus, on average 10(5) cells, corresponding to approximately 0.2 % of the total population of cells in the adult brain, are in S-phase within any period of 2 h. At least a portion of these newly generated cells survive for the rest of the fish's life. This long-term survival, together with the persistent generation of new cells, leads to a continuous growth of the brain during adulthood. Zones of high proliferative activity are typically located at or near the surface of the ventricular, paraventricular and cisternal systems. In the central posterior/ prepacemaker nucleus, for example, new cells are generated, at very high rates, in areas near the wall of the third ventricle. At least some of these cells differentiate into neurons, express immunoreactivity against the neuropeptide somatostatin and migrate into more lateral areas of this complex. Approximately 75 % of all new brain cells are generated in the cerebellum. In the corpus cerebelli and the valvula cerebelli, they are produced in the molecular layers, whereas in the eminentia granularis the newborn cells stem from proliferation zones in the pars medialis. Within the first few days of their life, these cells migrate towards specific target areas, namely the associated granule cell layers. At least some of them develop into granule neurons. The high proliferative activity is counterbalanced by apoptosis, a mechanism that resembles the processes known from embryonic development of the vertebrate brain. Apoptosis also appears to be used as an efficient mechanism for the removal of cells damaged through injury in the brain of adult Apteronotus leptorhynchus. Since apoptosis is not accompanied by the side effects known from necrosis, this ‘clean’ type of cell death may, together with the enormous proliferative activity in the brain, explain, at least partially, the tremendous capability of teleost fish to replace damaged neurons with newly generated ones. One factor that appears to play a major role in the generation of new cells and in their further development is the neuropeptide somatostatin. In the caudal cerebellum of the gymnotiform brain, somatostatin-binding sites are expressed, at extremely high densities, at sites corresponding to the areas of origin, migration and differentiation of the newborn cells. This pattern of expression resembles the expression pattern in the rat cerebellum, where somatostatin immunoreactivity and somatostatin-binding sites are transiently expressed at the time when the granule cells of the cerebellum are generated. Moreover, after mechanical lesions of the corpus cerebelli, the expression of somatostatin-like immunoreactivity is tremendously increased in several cell types (presumably astrocytes, microglia and granule cell neurons) near the path of the lesion; the time course of this expression coincides with the temporal pattern underlying the recruitment of new cells incorporated at the site of the lesion.

Characterisation of the fish sst3 receptor, a member of the SRIF1 receptor family: atypical pharmacological features

The first cloned non-mammalian somatostatin (somatostatin release-inhibiting factor = SRIF) receptor previously obtained from the teleost fish Apteronotus albifrons and generically named somatostatin receptor 3 (fsst3), was stably expressed and characterised in Chinese hamster lung fibroblast (CCL39) cells. Radioligand binding studies were performed with four radioligands selective for SRIF receptors in CCL39 cells expressing the fsst3 receptors; [125I]LTT-SRIF28 ([Leu8, D-Trp22, 125I-Tyr25]-SRIF28), [125I]Tyr10-cortistatin, [125I]CGP 23996, and [125I]Tyr3-octreotide labelled the fsst3 receptor with high affinity (pKd values: 10.47, 10.87, 9.59 and 9.57) and in a saturable manner, but defined different Bmax values; 4500, 4000, 3400 and 1500 fmol/mg, respectively. The affinities of SRIF peptides and analogues determined for fsst3 receptors displayed the following rank order of potency: seglitide = SRIF25 > SRIF14 = SRIF28 > cortistatin 14 > BIM 23014 > RC160 = L361,301 = octreotide > or = BIM 23052 > or = L362,855 > CGP23996 > BIM 23056 > BIM 23030 = cycloantagonist > SRIF22. The pharmacological profiles determined with [125I]LTT-SRIF28, [125I]CGP 23996 and [125I]Tyr10-cortistatin correlated highly significantly (r = 0.96-0.99), whereas [125I]Tyr3-octreotide binding was rather divergent (r = 0.78-0.81). Further, [125I]Tyr3-octreotide- and [125I]CGP 23996-labelled sites showed higher affinity for the various peptides than [125I]LTT-SRIF28 and [125I]Tyr10-cortistatin-labelled sites, although there were exceptions. [125I]LTT-SRIF28-binding to fsst3 receptors and human sst1-5 receptors was compared; the fsst3 binding profile correlated better with the hsst5- than with the hsst3 receptor profile. SRIF inhibited potently forskolin-stimulated adenylate cyclase activity in fsst3 transfected CCL39 cells; this effect was blocked by pertussis toxin, suggesting coupling of the fsst3 receptor to Gialpha and/or Goalpha. [125I]LTT-SRIF28 binding was detected in fish brain, liver, heart, spleen, and stomach, but not in gut. The pharmacological profile of [125I]LTT-SRIF28-labelled sites in brain, but not in liver, correlated significantly with the recombinant fsst3 receptor, in agreement with expression of the fsst3 receptor gene found by RT-PCR in the brain. However, biphasic binding curves obtained with two SRIF-analogues in brain, as well as the distinct pharmacological profile of the liver SRIF receptor, suggest the existence of several yet to be defined SRIF receptor subtypes in fish. The present data demonstrate that the recombinantly expressed fsst3 receptor has a pharmacological profile compatible with that of a SRIF1 receptor, although the rank order of affinity of fsst3 is closer to that of hsst5 than hsst3 receptors, as may be found when comparing very distantly related species. The fsst3 receptor expressed in CCL39 cells, is negatively coupled to adenylate cyclase activity via pertussis toxin-sensitive G-proteins, like mammalian sst3 receptors. Radioligand binding performed with fish tissue suggests the presence of a native sst3 receptor in brain as well as other yet to be defined SRIF receptor subtypes.

Somatostatin binding to hepatocytes isolated from rainbow trout, Oncorhynchus mykiss, is modulated by insulin and glucagon

Previously we reported somatostatin-14 (SS-14) binding in the liver of rainbow trout and that fasting enhanced SS-14-binding capacity. In this study, we used hepatocytes isolated from rainbow trout to study aspects of SS-14 processing and to evaluate the basis of fasting-associated changes in SS-14 binding. Hepatocytes specifically bound 5-8% of the total 125I-SS-14 added. Scatchard analysis revealed the existence of two classes of binding sites. The high-affinity site had a dissociation constant (Kd) of 23.6 +/- 1.1 nM and a binding capacity (Bmax) of 3459 +/- 134 receptors/cell. The low-affinity site had a Kd of 764 +/- 27 nM and a Bmax of 17,432 +/- 345 receptors/cell. 125I-SS-14 dissociation was hastened by the presence of 10(-6) M SS-14 . The internalization of 125I-SS-14 was time dependent; preincubation of hepatocytes with 10(-6) M SS-14 reduced internalization of 125I-SS-14. The number of high-affinity binding sites was also reduced by 10(-6) M SS-14. Because plasma levels of insulin (INS) decline relative to those of glucagon (GLU) during fasting of trout, we also investigated the effects of these hormones on SS-14 binding. The number of high-affinity SS-14-binding sites was reduced by 10(-6) M INS and was increased by 10(-6) M and 10(-8) M GLU. These results indicated that SS-14 regulates aspects of SS-14 binding and processing and suggests that INS and GLU play a role in fasting-associated changes in SS-14 binding.

Long-term inhibitory effects of somatostatin and insulin-like growth factor 1 on growth hormone release by serum-free primary culture of pituitary cells from European eel (Anguilla anguilla)

To investigate the ability of hypothalamic and peripheral factors to directly regulate growth hormone (GH) release in a primitive teleost, the European eel (Anguilla anguilla L.), we used primary cultures of dispersed pituitary cells. When cultured for 12 days in a serum-free medium, pituitary cells continuously released large amounts of GH, which exceeded the initial cellular content. Somatotropin-release inhibiting hormone (SRIH-14) dose-dependently inhibited GH release (EC50 0.75 nM) up to a maximal inhibitory effect of 95%. No desensitization of somatotropes to SRIH was observed over the 12 days of culture. Use of receptor subtype-selective SRIH agonists suggests the existence on eel somatotropes of SRIH receptor(s) related to the mammalian sst2/sst3/sst5 class rather than to the sst1/sst4 class. Insulin-like growth factor 1 (IGF1) dose-dependently inhibited GH release (EC50 0.03 nM) up to a maximal inhibitory effect of 85%, without desensitization. IGF1 and IGF2 were equipotent in inhibiting GH release, whereas insulin was 1,000 times less active, suggesting the implication of a receptor related to the mammalian IGF type 1 receptor. These results indicate that eel somatotropes are active in vitro without any specific additional factors, and suggest the existence of a dominant inhibitory control of GH release in vivo. Two potential candidates for this chronic negative regulation are a neurohormone, SRIH and a circulating factor, IGF1. These data underline the early evolutionary origin of the molecular and functional SRIH-GH-IGF1 neuroendocrine axis in vertebrates.

Expression of somatostatin in neurons of the central posterior/prepacemaker nucleus projecting to the preglomerular nucleus: immunohistochemical evidence for a non-synaptic function

In the diencephalon of the weakly electric gymnotiform fish Apteronous leptorhynchus, part of the central posterior/prepacemaker nucleus innervates the preglomerular nucleus. A minor population of these neurons expresses immunoreactivity against somatostatin, as has been shown by combining peptide immunohistochemistry with an in vitro tract-tracing technique. In contrast to the expectation, however, this neuropeptide does not appear to be transported along the axons to the projection site, as somatostatin-like immunoreactivity could not be detected in the preglomerular nucleus. It is, therefore, likely that somatostatin expressed in these neurons exerts a non-synaptic function in the region of the central posterior/prepacemaker nucleus itself.

The postembryonic development of somatostatin immunoreactivity in the central posterior/prepacemaker nucleus of weakly electric fish, Apteronotus leptorhynchus: a double-labelling study

The neuropeptide somatostatin (SS) is widely distributed in both the central and peripheral nervous system of vertebrates. Its widespread distribution is paralleled by a large variety of diverse functions. While embryonic and perinatal development of SS-like immunoreactivity have been well examined, little is known about the postnatal development of this neuropeptide. Since, in teleosts, neurogenesis persists in many brain regions during adulthood, these vertebrates are well suited to investigate this phenomenon. In the present study, we have, therefore, examined the development of somatostatinergic cells born during adulthood in the central posterior/prepacemaker nucleus (CP/PPn) of Apteronotus leptorhynchus, a weakly electric gymnotiform fish. This was achieved by labelling proliferating cells with the thymidine analogue 5-bromo-2'-deoxyuridine (BrdU) and by simultaneous immunocytochemical detection of SS-like immunoreactivity. SS-like immunoreactivity is adopted in a period between 2 days and 3.5 days after birth. While the number of BrdU-labelled cells in the CP/PPn decreases 10 days after birth, the percentage of double-labelled cells among the BrdU-labelled cells remains with 1.0-7.6% in the period between 3.5 days and 100 days after birth rather constant. This percentage matches well the fraction of SS-positive cells in the total population of cells present in the CP/PPn.

Peptidergic transmission: from morphological correlates to functional implications

Like non-peptidergic transmitters, neuropeptides and their receptors display a wide distribution in specific cell types of the nervous system. The peptides are synthesized, typically as part of a larger precursor molecule, on the rough endoplasmic reticulum in the cell body. In the trans-Golgi network, they are sorted to the regulated secretory pathway, packaged into so-called large dense-core vesicles, and concentrated. Large dense-core vesicles are preferentially located at sites distant from active zones of synapses. Exocytosis may occur not only at synaptic specializations in axonal terminals but frequently also at nonsynaptic release sites throughout the neuron. Large dense-core vesicles are distinguished from small, clear synaptic vesicles, which contain "classical' transmitters, by their morphological appearance and, partially, their biochemical composition, the mode of stimulation required for release, the type of calcium channels involved in the exocytotic process, and the time course of recovery after stimulation. The frequently observed "diffuse' release of neuropeptides and their occurrence also in areas distant to release sites is paralleled by the existence of pronounced peptide-peptide receptor mismatches found at the light microscopic and ultrastructural level. Coexistence of neuropeptides with other peptidergic and non-peptidergic substances within the same neuron or even within the same vesicle has been established for numerous neuronal systems. In addition to exerting excitatory and inhibitory transmitter-like effects and modulating the release of other neuroactive substances in the nervous system, several neuropeptides are involved in the regulation of neuronal development.

Apoptosis as a regulator of cell proliferation in the central posterior/prepacemaker nucleus of adult gymnotiform fish, Apteronotus leptorhynchus

Like many species of teleost fish, the gymnotiform Apteronotus leptorhynchus displays a high degree of proliferative activity in a large number of brain regions during adulthood. One of these regions is the central posterior/prepacemaker nucleus (CP/PPn) in the diencephalon. By applying in situ techniques for the detection of DNA fragmentation, a feature characteristic of apoptotic cells, we show in the present study that the high proliferative activity in the CP/PPn is counterbalanced by programmed cell death. Most of the apoptotic events occur in the ventricular and subventricular zones of this thalamic complex, where the generation of the cells and their differentiation into neurons take place. The demonstration of apoptosis in the CP/PPn provides strong evidence against the hypothesis that animals in which neurogenesis continues beyond embryonic stages of development lack cell death.

Somatostatin in the prepacemaker nucleus of weakly electric fish, Apteronotus leptorhynchus: evidence for a nonsynaptic function

Neuropeptides are widely distributed throughout the nervous system and exert a large number of heterogeneous functions. While they are synthesized in the soma, release is thought to take place in axonal terminals of neurons. A good model system to investigate the role of peptides in the nervous system is provided by the central posterior/prepacemaker nucleus (CP/PPn) of pacemaker nucleus (Pn), a medullary cell group controlling the electric organ discharge (EOD). Previous immunocytochemical and in situ-hybridization studies employing topographical criteria indicated that PPn neurons may express the neuropeptide somatostatin (SS). In the present study, we unambiguously identified PPn neurons by in vitro tract tracing. By combining this technique with SS immunocytochemistry, we found that a large portion of retrogradely labelled PPn neurons exhibited SS-like immunoreactivity (72-89%, n = 708 cells in 10 fish examined). Surprisingly, however, neither the proximal PPn axons nor anterogradely labelled terminals innervating the Pn displayed significant amounts of SS-like immunolabelling (n = 10 fish examined in each experiment). These results and the lack of SS binding sites in the Pn [82] suggest that SS expressed by PPn cells is not synaptically released at the target site of their axons, the Pn, but acts via a nonsynaptic mechanism in the CP/PPn proper.

The distribution of tachykinin binding sites in the brain of an electric fish (Apteronotus leptorhynchus)

We mapped the distribution of tachykinin binding sites utilizing quantitative autoradiography of iodinated substance P and eledoisin as prototypic ligands for neurokinin-1 (NK1) and neurokinin-3 (NK3) receptors, respectively. The two ligands produced highly heterogenous and quantitatively different patterns of specific binding, suggesting that they revealed different tachykinin receptor subtypes. Although [125I]substance P and [125I]eledoisin binding were correlated in most brain regions, the binding of substance P was usually denser. [125I]substance P binding and substance P-like immunoreactivity were reasonably correlated in most brain areas, although discrepancies were found in some nuclei. Dense [125I]substance P binding was found in most areas of the subpallium and in parts of the pallium related to the olfactory system, as well as in the glomerular layer of the olfactory bulb. Moderate to dense binding of both ligands was observed in preoptic area, hypothalamus, habenula, parts of the thalamus and preglomerular complex. Especially noteworthy was the presence of [125I] substance P binding in the diencephalic prepacemaker nucleus, a region involved in the control of electroncommuncatory behavior. Substance P-like immunoreactivity is sexually dimorphic in certain diencephalic nuclei, including the prepacemaker nucleus (Weld and Maler, 1992); no obvious difference was seen between [125I]substance P or [125I]eledoisin binding in the brains of male versus female fish. In the mesencephalon striking laminar patterns of binding were seen in the torus semicircularis dorsalis and the optic tectum. Dense binding was also noted in the raphé nuclei, the locus ceruleus and the sensory nucleus of the vagus. Although binding of substance P in the electrosensory lateral line lobe and nucleus preeminentialis was light, it was distributed in a discrete fashion, suggesting a role of substance P in electrosensory processing.

Identification and localization of somatostatin-like immunoreactivity in the cerebellum of gymnotiform fish, Apteronotus leptorhynchus

Previous studies have shown major mismatches between the localization of the neuropeptide somatostatin of its mRNA and the distribution of somatostatin receptors in the cerebellum of gymnotiform fish. By employing highly sensitive immunohistochemical techniques, we re-examined these mismatches in the gymnotiform fish Apteronotus leptorhynchus. We found somatostatin-like immunoreactivity in the corpus cerebelli, valvula cerebelli, eminentia granularis anterior, eminentia granularis posterior, and transitional zone. While labelled somata were predominantly restricted to a region near the boundary between the granule cell layers and molecular layers, immunopositive processes were distributed throughout large areas within the respective molecular layer. These immunopositive cells appear to represent a novel cell type in the cerebellum of gymnotiform fish.